Analyzed outcome for embolization of hepatic carcinoma by C-arm angiographic computed tomography.
This study evaluated and monitored the outcome of angiographic embolization of hepatic carcinoma by real-time C-arm angiographic computed tomography under number of tumors, size of tumors, and patient's age.METHODS AND MARTIALS: In total, 142 patients underwent angiographic embolization of hepatic carcinoma. The control group, 71 patients, underwent conventional angiographic (CA) embolization of hepatic carcinoma. The experimental group, 71 patients, underwent C-arm angiographic computed tomography (CCT) embolization of hepatic carcinoma. The numbers of angiographic embolization, number of tumors, size of tumors, and patients ages were recorded for comparisons between groups by analysis of variance (ANOVA) with cross-interaction and the chi-square test (cross table). The age ranges were 20-84 and 35-84 years old for the experimental and control groups respectively. Average number of angiographic embolizations of hepatic carcinomas were 2.63 ± 1.84 and 5.32 ± 2.01 for the experimental and control groups. The number of angiographic embolizations under number of tumors, size of tumors, and patients ages between groups were significantly different (P< 0.05). The effective analyses of transcatheter arterial chemoembolization (TACE) by CCT were significant by chi-square test (P< 0.05) under ⩽ 3 cm and patients aged ⩽ 60. The main advantage by CCT for undergoing TACE under tumor size smaller than 3 cm and numbers of tumor smaller 3 times were more significantly effective than those by CA. The CCT combined with TACE had high potentially reduced numbers of undergoing TACE.